Anchor Investment Management LLC Sells 1,471 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Anchor Investment Management LLC decreased its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,398 shares of the pharmacy operator’s stock after selling 1,471 shares during the quarter. Anchor Investment Management LLC’s holdings in Walgreens Boots Alliance were worth $75,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Iron Horse Wealth Management LLC lifted its position in shares of Walgreens Boots Alliance by 162.5% during the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 1,300 shares during the last quarter. Blue Trust Inc. raised its stake in Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 1,081 shares in the last quarter. TD Private Client Wealth LLC lifted its holdings in shares of Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after acquiring an additional 3,208 shares during the last quarter. Continuum Advisory LLC boosted its stake in shares of Walgreens Boots Alliance by 71.2% in the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 1,020 shares in the last quarter. Finally, Sentry Investment Management LLC bought a new stake in shares of Walgreens Boots Alliance during the 3rd quarter valued at approximately $30,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

WBA has been the topic of a number of research analyst reports. UBS Group raised their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Barclays boosted their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. Jefferies Financial Group dropped their target price on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, October 23rd. Royal Bank of Canada reduced their price target on Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a report on Wednesday, December 4th. Finally, Bank of America dropped their price objective on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a report on Wednesday, September 4th. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $12.58.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $10.39 on Friday. The firm has a market cap of $8.98 billion, a PE ratio of -1.04, a price-to-earnings-growth ratio of 1.36 and a beta of 0.66. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $27.05. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The business’s 50 day moving average price is $9.27 and its two-hundred day moving average price is $10.72.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.03. The business had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. Walgreens Boots Alliance’s revenue was up 5.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.67 earnings per share. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were issued a $0.25 dividend. The ex-dividend date was Monday, November 18th. This represents a $1.00 annualized dividend and a yield of 9.62%. Walgreens Boots Alliance’s payout ratio is currently -9.99%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.